P 
POMDOCTOR LIMITED American Depositary Shares POM · USD
Health Care · US listing · 🇺🇸 United States
1.55
-14.36%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$59.6m
FY2016FY2025
Net income
−$31.7m
FY2016FY2025
Free cash flow
−$22.3m
FY2016FY2025
Shareholders' equity
−$67.6m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.6m | $51.0m | $45.4m | $36.5m | $32.1m | $21.0m | $5.13bn | $5.36bn | $4.99bn | $4.67bn |
| Research and development | $1.9m | $447,187 | $502,139 | $534,457 | $637,843 | $295,691 | — | — | — | — |
| Operating income | −$17.3m | −$3.8m | −$3.3m | −$535,407 | −$11.9m | −$35.8m | $651.6m | $580.6m | $634.6m | $463.6m |
| Net income | −$31.7m | −$21.4m | −$21.7m | −$18.7m | −$28.1m | −$38.2m | $451.1m | $59.3m | $401.3m | $168.9m |
| Diluted earnings per share | -1.37 | -1.08 | -2.80 | -2.42 | -3.63 | -0.04 | 0.46 | 0.06 | 0.42 | 0.18 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $16.0m | $6.9m | $9.9m | $7.2m | $2.9m | $11.5m | $1.00bn | $17.83bn | $17.38bn | $17.12bn |
| Cash and short-term investments | $1.4m | $1.1m | $1.0m | $370,257 | $323,369 | $1.8m | $24.3m | $320.7m | $279.2m | $231.2m |
| Total liabilities | $87.7m | $318.9m | $302.1m | $290.0m | $267.7m | $57.6m | $517.8m | $13.24bn | $12.94bn | $13.27bn |
| Debt | $67.8m | $65.7m | $61.6m | $53.8m | $50.8m | $17.0m | $100.4m | $5.28bn | $5.10bn | $5.07bn |
| Shareholders' equity | −$67.6m | −$337.2m | −$315.8m | −$294.1m | −$275.5m | −$46.1m | $487.0m | $4.58bn | $4.45bn | $3.85bn |
| Shares outstanding | 23m | 20m | 8m | 8m | 8m | 976m | 974m | 969m | 949m | 927m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$22.1m | −$2.4m | −$6.8m | −$3.3m | −$2.3m | −$5.2m | $12.7m | $1.29bn | $1.11bn | $1.26bn |
| Capital spending | −$150,116 | −$5,627 | −$16,667 | — | — | — | — | −$1.13bn | −$1.13bn | −$1.27bn |
| Free cash flow | −$22.3m | −$2.4m | −$6.8m | −$3.3m | −$2.3m | −$5.2m | $12.7m | $156.4m | −$15.5m | −$16.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2020 | Dec 2019 | Sept 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sept 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0m | $1.30bn | $1.24bn | $2.48bn | $1.15bn | $1.41bn | $1.31bn | $1.40bn |
| Operating income | −$5.1m | $181.7m | $143.3m | $326.8m | $125.4m | $181.4m | $105.6m | $170.7m |
| Net income | −$5.0m | $6.7m | $120.4m | $54.4m | $73.6m | $54.1m | $15.6m | $34.7m |
| Diluted earnings per share | -0.65 | 0.01 | 0.12 | 0.06 | 0.08 | 0.06 | 0.02 | 0.04 |
| Cash from operations | — | $160.0m | −$14.0m | $648.0m | $4.0m | $155.0m | $293.0m | $417.0m |
| Capital spending | — | −$300.0m | — | −$504.0m | — | −$279.0m | −$312.0m | −$251.0m |
| Free cash flow | — | −$140.0m | — | $144.0m | — | −$124.0m | −$19.0m | $166.0m |
| Total assets | $1.7m | $18.57bn | $1.00bn | $18.28bn | $2.88bn | $18.11bn | $17.83bn | $17.80bn |
| Cash and short-term investments | $276,851 | $314.8m | $24.3m | $340.2m | $27.9m | $228.2m | $320.7m | $389.4m |
| Debt | $1.7m | $424.2m | $19.4m | $632.8m | $157.7m | $373.6m | $200.9m | $114.8m |
| Shareholders' equity | −$10.3m | $4.84bn | $1.59bn | $4.77bn | $4.70bn | $4.67bn | $4.58bn | $4.62bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 17.7% | 23.1% | -22.4% |
| Operating income | 218.7% | -13.5% | — |
| Net income | 19.2% | -3.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -19.1% | -13.0% | -29.6% | 11.1% |
| Net margin | -47.9% | -48.5% | -65.0% | 4.6% |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | -2.2 |
| Price to sales | 1.2 |
Share price return
Finished calendar years
| 2025 | |
|---|---|
| Return | -92% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 3-to-1 reverse split · 21 Oct 2026
- 18-to-1 reverse split · 22 Jun 2026
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.